Company Filing History:
Years Active: 2019
Title: Manjarika De: Innovator in Cancer Treatment
Introduction
Manjarika De is a notable inventor based in Jadavpur, India. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on creating effective therapeutic solutions that enhance the efficacy of existing cancer treatments.
Latest Patents
Manjarika De holds a patent for a "Synergistic liposomal formulation for the treatment of cancer." This patent describes a synergistic liposomal formulation that includes phosphatidylcholine, stearylamine, and anticancer drugs. The formulation demonstrates enhanced synergistic anti-cancer effects and provides an improved therapeutic index compared to either the liposome or the drug alone. The cationic liposome encapsulated camptothecin (CPT) and doxorubicin (DOX) formulations show promising results against cancer both in vitro and in vivo, without causing adverse effects on the host.
Career Highlights
Manjarika De is affiliated with the Council of Scientific & Industrial Research, where he continues to advance his research in cancer therapeutics. His dedication to innovation in this critical field has positioned him as a key figure in the scientific community.
Collaborations
Manjarika has collaborated with notable colleagues, including Nahid Ali and Triparna Sen, who contribute to his research efforts and enhance the impact of his work.
Conclusion
Manjarika De's innovative approach to cancer treatment through his patented liposomal formulation exemplifies the potential of scientific research to improve therapeutic outcomes. His contributions are paving the way for more effective cancer therapies in the future.